Skip to search formSkip to main contentSkip to account menu

Anticancer Drugs - Consent type

Known as: Anticancer Drugs 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Analysis of a Questionnaire Survey regarding Current Conditions against Exposure to Anticancer Drugs and Reports of Cancer Chemotherapy at Outpatient Departments in Japan
[Background] Medical staff have many occasions to be exposed to anticancer drugs (ACDs) in the process of performing cancer… 
Review
2016
Review
2016
Current situation and future usage of anticancer drug databases
Cancer is a deadly disease with increasing incidence and mortality rates and affects the life quality of millions of people per… 
2016
2016
[Safety evaluation of anticancer drugs circuit in a regional hospital in Tunisia].
INTRODUCTION Nowadays, the circuit of drugs is a plague. This situation may cause serious harm to patients. In this context, we… 
2014
2014
Capillary electrophoresis separation of aminoalkanol derivatives of 1,7-dimethyl-8,9-diphenyl-4-azatricyclo[5.2.1.0(2,6)]dec-8-ene-3,5,10-trione as potential anticancer drugs.
The purpose of this study, the direct separation of aminoalkanol derivatives I and II of 1,7-dimethyl-8,9-diphenyl-4-azatricyclo… 
Review
2014
Review
2014
[Clinical application, limits and perspectives of pharmacogenetic and pharmacokinetic analysis of anticancer drugs].
Despite significant progress in the discovery and design of drugs, the interindividual variability to the standard dose of a… 
2010
2010
Drug-Drug Interactions between Oral Antiepileptics and Oral Anticancer Drugs: Implications to Clinicians
Background: Existing research has suggested that there can be potential drug-drug interaction (DDI) between antiepileptic drugs… 
2008
2008
Distinguishing compounds with anticancer activity by ANN using inductive QSAR descriptors
This article describes a method developed for predicting anticancer/non-anticancer drugs using artificial neural network (ANN… 
Review
2006
Review
2006
Fluorescence studies of anti-cancer drugs--analytical and biomedical applications.
The fluorescence properties of anticancer drugs (ACDs), including steady-state native fluorescence, time-resolved fluorescence… 
2004
2004
Pediatric phase I trial and pharmacokinetic study of P-glycoprotein inhibitor, tariquidar, in combination with doxorubicin, vinorelbine or docetaxel
8541 Background: P-glycoprotein (Pgp), an ATP-dependent membrane transporter present in normal tissues, confers multidrug… 
Review
1997
Review
1997
[SDZ PSC 833: a novel modulator of MDR].
SDZ PSC 833 is a novel compound able to reverse the resistance to chemotherapy of cancer cells with the multidrug resistance (MDR… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)